Mycosis Fungoides: Epidemiology in Isfahan, Iran

Document Type : Original Article (s)

Authors

1 Associate Professor, Skin Diseases and Leishmaniasis Research Center AND Department of Dermatology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

2 Assistant Professor, Cardiovascular Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran

3 Department of Genetics and Molecular Biology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

4 Skin and Stem Cell Research Center, Tehran University of Medical Sciences, Tehran AND Skin Diseases and Leishmaniasis Research Center, Isfahan University of Medical Sciences, Isfahan, Iran

5 Associate Professor, Skin and Stem Cell Research Center, Tehran University of Medical Sciences, Tehran, Iran

6 Isfahan University of Medical Sciences, Isfahan, Iran

Abstract

Background: Mycosis fungoides (MF) is the most common and indolent form of cutaneous T-cell lymphomas (CTCL), that usually occurs in old adults. We aimed to determine epidemiologic features and patients' characteristics of Mycosis fungoides in Isfahan, Iran.Methods: We performed a retrospective study in Mycosis fungoides clinic of Alzahra hospital, that is the main center for treatment of patients with Mycosis fungoides in Isfahan, and evaluated clinicopathologic features of the disease.Findings: In 3 years, from 25 referred patients, 18 were diagnosed as Mycosis fungoides. Seven (38.9%) patients were men and 11 (61.1%) were women with male to female ratio of 1:1.57. The mean age of patients was 41.06 years. 88.9% of patients were in stages ΙA and ΙB.Conclusion: Most of our patients presented in early stages that were similar to other studies; while male to female ratio was different from other studies.

Keywords

References

  1. Parker SR, Bethaney JV. Cutaneous T cell lymphoma-mycosis fungoides and Sezary syndrome: an update. G Ital Dermatol Venereol 2009; 144(4): 467-85.
  2. Samuelson E. Cutaneous T-cell lymphomas. Semin Oncol Nurs 1998; 14(4): 293-301.
  3. Weinstock MA, Gardstein B. Twenty-year trends in the reported incidence of mycosis fungoides and associated mortality. Am J Public Health 1999; 89(8): 1240-4.
  4. Patel SP, Holtermann OA. Mycosis fungoides: an overview. J Surg Oncol 1983; 22(4): 221-7.
  5. Worobec-Victor SM. Cutaneous T cell lymphoma. N J Med 1989; 86(5): 395-400.
  6. Pimpinelli N, Olsen EA, Santucci M, Vonderheid E, Haeffner AC, Stevens S, et al. Defining early mycosis fungoides. J Am Acad Dermatol 2005; 53(6): 1053-63.
  7. Zackheim HS, McCalmont TH. Mycosis fungoides: the great imitator. J Am Acad Dermatol 2002; 47(6): 914-8.
  8. Morales-Suarez-Varela MM, Olsen J, Johansen P, Kaerlev L, Guenel P, Arveux P, et al. Occupational risk factors for mycosis fungoides: a European multicenter case-control study. J Occup Environ Med 2004; 46(3): 205-11.
  9. Whittemore AS, Holly EA, Lee IM, Abel EA, Adams RM, Nickoloff BJ, et al. Mycosis fungoides in relation to environmental exposures and immune response: a case-control study. J Natl Cancer Inst 1989; 81(20): 1560-7.
  10. Wohl Y, Tur E. Environmental risk factors for mycosis fungoides. Curr Probl Dermatol 2007; 35: 52-64.
  11. Swerdlow SH, Campo E, Harris L. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon, France: International Agency for Research on Cancer; 2008.
  12. Olsen E, Vonderheid E, Pimpinelli N, Willemze R, Kim Y, Knobler R, et al. Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC). Blood 2007; 110(6): 1713-22.
  13. van Dongen JJ, Langerak AW, Bruggemann M, Evans PA, Hummel M, Lavender FL, et al. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia 2003; 17(12): 2257-317.
  14. Lee MW. Characteristics of cutaneous lymphomas in Korea. Clin Exp Dermatol 2003; 28(6): 639-46.
  15. Assaf C, Gellrich S, Steinhoff M, Nashan D, Weisse F, Dippel E, et al. Cutaneous lymphomas in Germany: an analysis of the Central Cutaneous Lymphoma Registry of the German Society of Dermatology (DDG). J Dtsch Dermatol Ges 2007; 5(8): 662-8.
  16. Ishiji T, Takagi Y, Niimura M. Cutaneous lymphomas in Tokyo: analysis of 62 cases in a dermatology clinic. Int J Dermatol 2001; 40(1): 37-40.
  17. McFadden N, Nyfors A, Tanum G, Granholt A, Helme P, Kavli G. Mycosis Fungoides in Norway 1960-1980: A Retrospective Study. Stockholm, Sweden: Almqvist & Wiksell periodical Company (distr.) 1-13; 1983.
  18. Criscione VD, Weinstock MA. Incidence of cutaneous T-cell lymphoma in the United States, 1973-2002. Arch Dermatol 2007; 143(7): 854-9.
  19. Gurney KA, Cartwright RA. Increasing incidence and descriptive epidemiology of extranodal non-Hodgkin lymphoma in parts of England and Wales. Hematol J 2002; 3(2): 95-104.
  20. Ku LS, Lo KK. Mycosis fungoides--a retrospective study of 40 cases in Hong Kong. Int J Dermatol 2005; 44(3): 215-20.
  21. Herizchi Qadim H, Azimi H, Golforooshan F, Aghdam Yousefi N. Demographic and Clinical Features of Mycosis Fungoides in Tabriz, Iran. Iranian Journal of Medical Sciences 2002; 34(2): 152. [In Persian].
  22. Khooei AR, Keramat MR. Cutaneous lymphomas and pseudolymphomas: A ten-year study at Emam Reza and Omid hospitals in Mashhad, using immunohistochemical and new classification methods. Iranian Journal of Dermatology 2005; 8(3): 201-10. [In Persian].
  23. Manuchehri HM, Rakhshan M. Characteristics of primary cutaneous lymphomas in Tehran, Iran (1998-2004). J Eur Acad Dermatol Venereol 2006; 20(6): 758-60.
  24. Salehi M, Azimi Z, Fatemi F, Rajabi P, Kazemi M, Amini G. Incidence rate of mycosis fungoides in Isfahan (Iran). J Dermatol 2010; 37(8): 703-7.
  25. Kim EJ, Lin J, Junkins-Hopkins JM, Vittorio CC, Rook AH. Mycosis fungoides and sezary syndrome: an update. Curr Oncol Rep 2006; 8(5): 376-86.
  26. Zinzani PL, Ferreri AJ, Cerroni L. Mycosis fungoides. Crit Rev Oncol Hematol 2008; 65(2): 172-82.
  27. Tan ES, Tang MB, Tan SH. Retrospective 5-year review of 131 patients with mycosis fungoides and Sezary syndrome seen at the National Skin Centre, Singapore. Australas J Dermatol 2006; 47(4): 248-52.
  28. Alsaleh QA, Nanda A, Al-Ajmi H, Al-Sabah H, Elkashlan M, Al-Shemmari S, et al. Clinicoepidemiological features of mycosis fungoides in Kuwait, 1991-2006. Int J Dermatol 2010; 49(12): 1393-8.
  29. van Doorn R, Van Haselen CW, van Voorst Vader PC, Geerts ML, Heule F, de Rie M, et al. Mycosis fungoides: disease evolution and prognosis of 309 Dutch patients. Arch Dermatol 2000; 136(4): 504-10.
  30. Thurber SE, Zhang B, Kim YH, Schrijver I, Zehnder J, Kohler S. T-cell clonality analysis in biopsy specimens from two different skin sites shows high specificity in the diagnosis of patients with suggested mycosis fungoides. J Am Acad Dermatol 2007; 57(5): 782-90.
  31. Xu C, Wan C, Wang L, Yang HJ, Tang Y, Liu WP. Diagnostic significance of TCR gene clonal rearrangement analysis in early mycosis fungoides. Chin J Cancer 2011; 30(4): 264-72.
  32. Hsiao PF, Hsiao CH, Lin YC, Tseng MP, Tsai TF, Jee SH. Histopathologic-molecular correlation in early mycosis fungoides using T-cell receptor gamma gene rearrangement by polymerase chain reaction with laser capture microdissection. J Formos Med Assoc 2007; 106(4): 265-72.
  33. Kandolf SL, Cikota B, Stojadinovic O, Basanovic J, Skiljevic D, Medenica L, et al. TCRgamma gene rearrangement analysis in skin samples and peripheral blood of mycosis fungoides patients. Acta Dermatovenerol Alp Panonica Adriat 2007; 16(4): 149-55.
  34. Morales-Suarez-Varela MM, Olsen J, Johansen P, Kaerlev L, Guenel P, Arveux P, et al. Occupational exposures and mycosis fungoides. A European multicentre case-control study (Europe). Cancer Causes Control 2005; 16(10): 1253-9.
  35. Morales-Suarez-Varela MM, Olsen J, Johansen P, Kaerlev L, Guenel P, Arveux P, et al. Occupational sun exposure and mycosis fungoides: a European multicenter case-control study. J Occup Environ Med 2006; 48(4): 390-3.
Journal of Isfahan Medical School
Volume 31, Issue 269 - Serial Number 269
November and December 2014
Pages 2301-2308

Files

History

  • Receive Date: 22 January 2014
  • Revise Date:
  • Accept Date: 06 April 2022

Share

How to cite

Statistics